Dror Ortho-Design, Inc.
DROR
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | -100.00% |
| 2024 | -0.65 | -100.00% |
| 2023 | -831.49K | 6,122,049.17% |
| 2022 | -13.58 | -91.37% |
| 2021 | -157.38 | 63.62% |
| 2020 | -96.19 | 838.13% |
| 2019 | -10.25 | 179.80% |
| 2018 | -3.66 | 120.84% |
| 2008 | -1.66 | -52.19% |
| 2007 | -3.47 | -55.54% |
| 2006 | -7.81 | -34.00% |
| 2005 | -11.83 | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 40.19 | - |
US
|
|
| 25.15 | - |
IE
|
|
| 32.77 | - |
US
|
|
| 18.71 | - |
US
|
|
| 60.54 | - |
US
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.
Questions about Dror Ortho-Design, Inc.'s P/E ratio
What was Dror Ortho-Design, Inc.'s P/E ratio in 2025?
In 2025, Dror Ortho-Design, Inc.'s P/E ratio was 0.00, compared with -0.65 in 2024.
How has Dror Ortho-Design, Inc.'s P/E ratio changed since 2020?
From 2020 to 2025, Dror Ortho-Design, Inc.'s P/E ratio was highest in 2025 (0.00) and lowest in 2023 (-831.49K).
How does Dror Ortho-Design, Inc.'s P/E ratio compare with similar companies?
Dror Ortho-Design, Inc.'s P/E ratio (0.00) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 60.54.